BI-2536 is a small molecule inhibitor of PLK1 and significantly reduced cell viability by inducing cell cycle arrest and cell apoptosis in neuroblastoma [40, 41] and triple-negative breast cancer [42]. This evidence concerns the gene PLK1 and triple-negative breast carcinoma.